The potential of plants as a source of anti-malarial agents Dr Geoffrey M. Rukunga Kenya Medical Research Institute PO BOX 54840 NAIROBI E-mail.

Slides:



Advertisements
Similar presentations
MATERIALS AND METHODS Leaves and roots of Moringa stenopetala were collected around Arbaminch town (Southern Ethiopia) in October The plant parts.
Advertisements

MICS3 Data Analysis and Report Writing
Pneumonia: Past and Present
Doctors For Life International: An NGO’s perspective on Malaria in Southern Africa Bola Omoniyi, Ph.D. http:
Lecture 7 – NPs and The Pharmaceutical Industry. Artemisinin Artemisinin treats multi-drug resistant strains of malaria. It is a sesquiterpene lactone.
Focusing on design, experimental synthesis, model system, mechanization and results. BY ALEX PETER(A )
MALARIA History The disease How people get Malaria ( transmission) Symptoms and Diagnosis Treatment Preventive measures Where malaria occurs in the world.
DEVELOPMENT IN THE PRODUCTION AND EFFECTIVENESS OF ARTEMISININ Background Information Currently, there is an epidemic of malaria in third world countries,
Malaria  Malaria is a vector borne parasitic disease caused by the genus Plasmodium, affecting over 100 countries of the tropical and subtropical regions.
Geographic Factors and Impacts: Malaria IB Geography II.
MALARIA KILLS. Send a net. Save a life.. Mosquito Tag.
Truphena Mogaka M.P.H Student PUBH – Dr. Raymond Thron Term 2, 2011.
The University of Arizona
Make malaria history. Now Simon’s mother-in-law was suffering from a high fever, and they asked [Jesus] about her. Then he stood over her and rebuked.
Start on the T/F quiz at your desk…Let’s see what you already know.
F INDINGS National Institutes of Health National Institute of General Medical Sciences Science Without Borders Geneticist Dyann Wirth: Understanding the.
A New Treatment for Malaria: Artemisinin Prof. Dr. Talal Aburjai.
Plant-derived Insecticides. David S. Seigler Department of Plant Biology University of Illinois Urbana, Illinois USA
Lutheran Malaria Initiative. What is malaria? Transmitted from person to person through the bite of a MOSQUITO Life-threatening DISEASE Caused by a PARASITE.
Millennium development goal: Combating the spread of HIV/Aids.
9/11 “The Malaria epidemic is like loading up seven Boeing 747 airplanes each day then deliberately crashing them into Mt Kilamanjaro” Chairman Malaria.
The South African Malaria Initiative A Case Study E Jane Morris Bridging the Gap in Global Health Innovation - from Needs to.
PHYTOCHEMICAL CONSTITUENTS OF SOME MEDICINAL PLANTS USED BY THE NANDI PEOPLE OF KENYA Jeruto Pascaline *, Mutai Charles^ and Ouma George*^ *Kenya Plant.
Access to Medicines: Antimalarials WHO/UNICEF Technical Briefing Seminar 10 October 2007 Silvia Schwarte Supply Chain Management Global Malaria Programme.
Africa Herbal Antimalaria Meeting Nairobi, March 2006 Research on Traditional Medicines used for the Treatment of Malaria in WHO African Region Traditional.
General Parasitology Zoology 4104 Matthew Bolek, LSW 415
‘Plant-derived compounds in clinical trials’ (Saklani and Kutty, 2008)
Identification of New Inhibitors of Plasmodium falciparum Enoyl- ACP Reductase Symposium on: Advances in Parasitology “Education and Research in Parasitology.
Synthetically Engineered Artemisinin Lianne Ryan.
African medicinal plants against malaria
Jeruto Pascaline *, Mutai Charles^ and Ouma George*^
Quinoline Alkaloids In general, the alkaloids containing essentially the ‘quinoline’ nucleus include a series of alkaloids obtained exclusively from the cinchona.
AFRICA HERBAL ANTIMALARIA MEETING ORGANISED BY THE WORLD AGROFORESTRY CENTRE (ICRAF) AND THE ASSOCIATION FOR THE PROMOTION OF TRADITIONAL MEDICINE (PROMETRA.
Topic: Improving services for road crash victims and their families. Presented by: Casey Marenge.
NATURAL PRODUCTS FROM PLANT BIODIVERSITY AND MALARIA Dr. Joseph M Nguta, UNIVERSITY OF NAIROBI.
BLI Research Project By: Tiffany Hou Artemisinin.
Malaria Case management KPA conference. Presentation outline  Introduction  National malaria strategy  Case management targets  AMFm subsidy  The.
New antiplasmodial alkaloids from Stephania rotunda Lour. () Sothavireak BORY 1, Sok Siya BUN 2, Béatrice BAGHDIKIAN 2, Valérie MAHIOU 2, Nadine AZAS 2,
World Bank Seminar Series: Global Issues Facing Humanity Diseases without borders.
Jeruto Pascaline *, Mutai Charles^ and Ouma George*^
PREAICE GEOGRAPHY POPULATION AND SETTLEMENT. POPULATION DYNAMICS 1 MILLION YEARS AGO: 125,000 PEOPLE. 10,000 YEARS AGO WHEN PEOPLE DOMESTICATED ANIMALS,
Jair L. Siqueira-Neto Assistant Professor
HIV/AIDS Epidemic Disproportionately Affects Women.
Malaria By Alexandra Graziano 10 White What is this disease? Malaria is an infection of the blood caused by a parasite called Plasmodium, which.
Issues in malaria diagnosis and treatment May 31, 2007 Jacek Skarbinski, MD Malaria Branch Centers for Disease Control and Prevention.
Plants used to treat infectious disease - II Antimalarials.
Millennium Development Goals Presenter: Dr. K Sushma Moderator: Dr. S. S.Gupta.
In Africa.  Water scarcity or lack of safe drinking water is one of the world's leading problems affecting more than 1.1 billion people globally, meaning.
General Parasitology Zoology 4104 Matthew Bolek, LSW 415
Africa the other face of the world. Index Africa, the poorest continent Zambia, the poorest country Possible solutions.
Is antimalarial treatment in pregnant women as effective as that in non- pregnant women? Elizabeth Juma, Rashid Aman, Florence Oloo, Bernhards Ogutu Centre.
Global Health Malaria. Transmission Malaria is spread by mosquitoes carrying parasites of the Plasmodium type. Four species of Plasmodium are responsible.
Plants For Food and Fibre
Seasonal Malaria Chemoprevention: WHO Policy and Perspectives
MALARIA.
Main Points: Generally, the HIGHER the birth rate the less developed a country is! Niger = (Birth Rate: 53 per 1000 people) (GNP per capita: $220) Generally,
ARTEMISININ DR ANTHONY MELVIN CRASTO PRINCIPAL SCIENTIST india
Traditional Medicine & Drug Discovery
Malaria.
By: Abdul Aziz Timbilla Ahmad Adel Kamil Al-Quraishi
Cheryl Cole contracted malaria on a visit to Tanzania in 2010 and brought the disease to public attention in the west.
Warming and the Winged Assassin
Medicine in third world countries
Global Poverty at a Glance
Public Health Malaria.
Global Poverty at a Glance
Chemistry of natural products
US Army Medical Research and Materiel Command
Total number of species
Presentation transcript:

The potential of plants as a source of anti-malarial agents Dr Geoffrey M. Rukunga Kenya Medical Research Institute PO BOX NAIROBI

Global statistics of Malaria  1.5 – 2.7 million deaths annually  Over 1 billion clinical episodes  300 – 500 million people infected  Every 10 – 30 seconds a child dies of malaria

Impact of malaria in Africa  Major health problem in the tropics  About 90 million clinical cases annually.  Malaria leads to economic loss.  Most affected are pregnant women and children Under 5 years.

What contributes to the problem?  Resistance to conventional drugs.  Affordability of available drugs. There for need to continue searching for new agents

Plant drugs  Approximately 80% of the people in the developing countries depend on traditional medicine.  The discovery of quinine and artemisinin has stimulated interest in medicinal plants as sources of new antimalarial drugs.

Selection of plants for antimalarial activity  Ethno medical bases  Random selection

Methodologies  Extractions – water or organic solvent  In vitro assays – IC 50s  Cytotoxicity assays CC50’s  Selectivity index (S.I) = IC 50/CC50  In vivo assays – percentage chemosuppression of parasitaemia.  Toxicity in animals.  Activity guided isolation of the active compound (?)

So many publications yet few candidates anti-malarial agents  Anti-malarial compounds rare.  Most studies ends up with only in vitro assays.  If beyond in vitro assay – then toxicity - problem  Usually because of lack of resources - trained personnel - equipment - Finances

Categorization of plants extracts with in vitro anti-plasmodial activity  Category 1: High activity IC 50 equal or less than 10  g/mL  Category 2: Moderate activity IC 50 between 10 and 100  g/mL  Category 3: Low or no activity IC 50 Above 100  g/mL

Category 1 (High activities) 120 plant extracts from 74 plant species, belonging to 34 families. Some of the families with more species than others: Annonaceae (alkaloids) Apocynaceae (Alkaloids) Asteracea (sesquiterpenes) Celestraceae (Triterpenes) Meliaceae (limonoids) Simaroubaceae (quassinoids) Menispermaceae (Alkaloids) Rutaceae (Alkaloids) Rubiaceae (alkaloids)

Category 2 – moderate activities 203 plant extracts from 129 plant species, belonging to 50 families. Some of the families with more species than others: Annonaceae Asteraceae Meliaceae Loganiacea Fabaceae

Classes of compounds with high anti-malarial activities Alkaloids  Basic compounds -highly bioactive compounds.  The structures are very diverse  Families containing the compounds includes AnnonaceaeLoganiaceae MenispermaceaeAsclepiadaceae Dioncophyllaceae Rubiacea Rutaceae Apocynaceae

Quinine – An alkaloidal compound

Quassinoids  Heavily oxygenated lactones majority with C-20 basic skeleton.  The structures are very diverse  Simaroubaceae – is the family associated with quassinoids

A quassinoid from Simaba guianensis (Simaroubaceae) IC 50 < 1.7 ng/mL

Sesquiterpenes  Biosynthetically made from three 5-carbon isoprene units skeleton  Among the most active terpenoids  Artemisinin belongs to thisd class of compounds.  Families identified with highly active sesquiterpenes includes AsteraceaeSiparunaceae CyperaceaeValerianaceae Rosaceae

Artemisinin and Mustakone

Triterpenes Triterpenes.  Biosynthetically made from 6 units isoprene units  Diverse sructures. Some triterpenes have exhibited high anti-plasmodial activity. Families associated includes: -Ancistrocladaceae - Meliaceae - Simaroubaceae - Celestraceae

pristimerin – triterpene from Maytenus senegalensis - Celestraceae IC 50 < 200 ng/mL

Limonoids Tetranoterpenoids a class of compounds highly active. IC 50s < 1ug/mL Family associated with these compounds – Meliaceae

Discussions Points to consider in the categorization of the plant extracts with anti-plasmodial activity.  Type of extract  Strain of Plasmodium parasite used in the assay  Part of the plant extracted  Geographical location of plant  Time of the year harvested  Thus categorization is a guide

Way forward Prioritization of plants as source of anti-malarial agents.  Families whose exts have high anti-malarial activity (cat 1&2).  Families that contain class of compounds with known potent anti-malarial activity e.g liminoids, alkaloids, quassinoids etc.  Cytotoxicity after in vitro anti-plasmodial assays.  Confirm activity in vivo  Toxicity studies in animals.  plant part: leaves > stems > roots  Ease of propagation, cultivation etc  Team work – the only answer.

End Thank you